Backgraound
===========

The proportion of older patients in cardiac surgery is increasing as a consequence of demographic changes and new developments in medical technology. In the year 1989, 3673 patients in the age of 70 years and over underwent a cardiac surgical procedure in Germany, whereas in the year 2000 the number of operated patients in this age group increased to 35884. Thus, the proportion of patients aged 70 years and older increased from 11,2% to 36,7% \[[@B1],[@B2]\].

The EuroSCORE is one of the established risk evaluation scores in heart surgery in Europe \[[@B3]-[@B5]\]. In Germany, the EuroSCORE is presently being employed as a nation-wide quality control tool for the assessment of the 30-days mortality risk in cardiac surgery. It is based on a logistic regression model and includes all adult cardiac surgery procedures within a defined 30-days time interval. Besides other parameters, the age above 60 years is regarded as an independent determinant of mortality in this score system, whereby the risk weight is increased in 5-years intervals (table [1](#T1){ref-type="table"}; see also <http://www.euroscore.org/calc.html>). We have checked the effect of age on the mortality rate and the occurrence of postoperative complications in our institutional patients.

###### 

EuroScore (4)

  **Variable**                       **Definition and Scoring**                                                                                                                                                                                                                                                                                
  ---------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
  **Patient-related factors**                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                               
  Age (years)                        Per 5 years or part thereof over 60 years                                                                                                                                                                                                                                                                 1
  Gender                             Female                                                                                                                                                                                                                                                                                                    1
  Chronic pulmonary disease (COPD)   Long term use of bronchodilators or steroids for lung disease                                                                                                                                                                                                                                             1
  Extracardiac arteriopathy          Any one or more of the following: claudication, carotid occlusion or \>50% stenosis, previous or planned intervention on the abdominal aorta, limb arteries or carotids                                                                                                                                   2
  Neurological dysfunction           Disease severely affecting ambulation or day-to-day functioning                                                                                                                                                                                                                                           2
  Previous cardiac surgery           Surgery requiring opening of the pericardium                                                                                                                                                                                                                                                              3
  Serum creatinine                   Serum creatinine \> 200 μmol/l preoperatively                                                                                                                                                                                                                                                             2
  Active endocarditis                Patient still on antibiotic treatment for endocarditis at time of surgery                                                                                                                                                                                                                                 3
  Critical preoperative state        Any one or more of the following: ventricular tachycardia or fibrillation or aborted sudden death, preoperative cardiac massage, preoperative ventilation before anaesthetic room, preoperative inotropes or intra-aortic balloon pump, preoperative acute renal failure (anuria or oliguria \<10 ml/h)   3
  **Cardiac-related factors**                                                                                                                                                                                                                                                                                                                  
  Unstable angina                    Rest angina requiring intravenous nitrates until arrival in anaesthetic room                                                                                                                                                                                                                              2
  Left ventricular dysfunction       Moderate or left ventricular ejection fraction 30--50% Poor or left ventricular ejection fraction \<30%                                                                                                                                                                                                   13
  Recent myocardial infarction       Myocardial infarction within 90 days                                                                                                                                                                                                                                                                      2
  Pulmonary hypertension             Systolic pulmonary artery pressure \>60 mmHg                                                                                                                                                                                                                                                              2
  **Operation-related factors**                                                                                                                                                                                                                                                                                                                
  Emergency                          Carried out on referral before the beginning of the next working day                                                                                                                                                                                                                                      2
  Other than isolated CABG           Major cardiac procedure other than or in addition to CABG                                                                                                                                                                                                                                                 2
  Surgery on thoracic aorta          For disorders of ascending, arch or descending aorta                                                                                                                                                                                                                                                      3
  Postinfarction septal rupture                                                                                                                                                                                                                                                                                                                4
  Score                              Risk                                                                                                                                                                                                                                                                                                      Expected mortality (95% confidence limits)
  0--2                               Low                                                                                                                                                                                                                                                                                                       1,27--1,29%
  3--5                               Medium                                                                                                                                                                                                                                                                                                    2,90--2,94%
  ≥ 6                                High                                                                                                                                                                                                                                                                                                      10,93--11,54%

Methods
=======

Several patient files, for instance, the databases of the departments of anaesthesiology, clinical laboratory and institutional management, the database of the nation-wide quality control in cardiac surgery, internal follow-up information files and the databases of specific groups of patients, e.g. the patients requiring haemodialysis, are assembled in parallel in our institution. In cooperation with the Department of Neuroinformatics at the University in Bielefeld, we have created a new specialized database, bringing together the information from the already existing database systems. Using this specialized database, we have retrospectively studied a total of 8769 patients who underwent a cardiac surgery in the time interval between January 1996 and January 2002.

According to the established EuroSCORE evaluation procedure, our patients were divided into seven age groups. The EuroSCORE and the age-adjusted EuroSCORE values were calculated for each patient, in the latter case by subtracting the scoring points for the corresponding age group. Thereafter, the occurrence of postoperative complications and the 30-days mortality were determined. Finally, statistical analyses (Pearson\' Chi square test, ANOVA) were performed with the aim to establish the role of age in cardiac surgery. Statistical significance was defined as p \< 0.05. In addition to the EuroSCORE parameters, we have also determined the occurrence of arterial hypertension, diabetes mellitus, as well as atrial fibrillation in all age groups studied. The dependence of the 30-days mortality on these three variables was checked by univariate as well as stepwise logistic regression analyses.

Results
=======

The calculated EuroSCORE parameters in all age groups studied, as well as the occurrence of the three additionally determined accompanying diseases, are shown in table [2](#T2){ref-type="table"}. Highly significant age-dependent differences in the distribution of the following variables were found: female gender, chronic obstructive pulmonary disease (COPD), non-cardiac atherosclerosis, neurological dysfunction, instable angina, left ventricular ejection fraction 30--50%, non-isolated coronary artery bypass grafting (CABG), thoracic aortic surgery, arterial hypertension, diabetes and atrial fibrillation. Table [3](#T3){ref-type="table"} shows the EuroSCORE and the age-adjusted EuroSCORE values in the following three groups of patients: 1. all patients, 2. patients who were alive 30 days after surgery and 3. patients who died within 30 days after surgery. Both the EuroSCORE and the age-adjusted EuroSCORE values increased significantly with age in the group of all patients studied and in the group of 30-days survivors. In the group of patients who died within 30 days after cardiac surgery, the EuroSCORE exhibited a significant age-dependent increase, however, the age-adjusted EuroSCORE value did not change significantly with age.

###### 

Preoperative data

  Age group                        \< 60   61--65   66--70   71--75   76--80   81--85   86--90   p value
  -------------------------------- ------- -------- -------- -------- -------- -------- -------- ----------
  n                                2180    1539     1798     1731     1169     293      58       \-\--
  Female                           15,6%   22,2%    27,0%    38,1%    45,9%    59,7%    56,9%    \< 0,005
  COPD                             2,8%    3,8%     4,6%     5.0%     5,3%     7,2%     8,6%     \< 0,005
  Extracardiac arteriopathy        10,6%   15,7%    17,7%    19,2%    18,8%    15,7%    20,7%    \< 0,005
  Neurological dysfunction         2,6%    3,0%     4,7%     4,3%     4,0%     5,5%     1,7%     0,006
  Previous cardiac surgery         4,8%    4,8%     5,6%     4,6%     4,4%     3,1%     5,2%     0,658
  Serum creatinine \> 200 μmol/l   1,6%    1,6%     1,2%     2,5%     1,8%     0,7%     5,2%     0,038
  Active endocarditis              1,2%    0,5%     0,3%     0,7%     0,3%     0,7%     1,7%     0,014
  Critical preoperative state      0,8%    0,5%     0,6%     0,7%     0,4%     1,0%     1,7%     0,777
  Unstable angina                  9,4%    10,7%    11,2%    9,4%     11,8%    14,0%    27,0%    \< 0,005
  LV ejection fraction 30--50%     28,4%   28,0%    33,0%    34,4%    33,5%    37,2%    53,4%    \< 0,005
  LV ejection fraction \< 30%      4,3%    4,8%     5,6%     4,7%     5,5%     4,4%     6,9%     0,635
  Recent myocardial infarct        11,1%   9,4%     9,9%     9,5%     7,4%     9,2%     3,4%     0,034
  Pulmonary hypertension           5,1%    4,5%     4,5%     6,4%     6.0%     8,5%     6,9%     0,032
  Emergency                        1,4%    1,3%     1,1%     1,7%     1,5%     1,7%     5,2%     0,309
  Other than isolated CABG         15,0%   11,4%    10,4%    12,4%    15,0%    23,5%    24,1%    \< 0,005
  Surgery on thoracic aorta        2,6%    1,2%     1,0%     1,2%     0,5%     0,7%     0,0%     \< 0,005
  Postinfarction septal rupture    0,0%    0,1%     0,0%     0,0%     0,0%     0,0%     0,0%     0,157
  Arterial hypertension            62,2%   70,1%    74,0%    74,6%    71,7%    67,2%    100%     \< 0,005
  Diabetes mellitus                20,1%   27,6%    28,8%    29,6%    29,9%    27,6%    17,2%    \< 0,005
  Atrial fibrillation              2,9%    4,8%     6,1%     9,5%     9,8%     14,7%    13,8%    \< 0,005

###### 

EuroScore and age-stripped EuroScore

  **All patients**                                                                                              
  ---------------------------------------------------------- ---------- -------------- ------------------------ ------------------------
  Age group                                                  N          EuroScore      Age-stripped EuroScore   
  \< 60                                                      2180       2,35 ± 0,05    2,35 ± 0,05              
  61--65                                                     1539       3,45 ± 0,06    2,45 ± 0,06              
  66--70                                                     1798       4,72 ± 0,06    2,72 ± 0,06              
  71--75                                                     1731       6,06 ± 0,07    3,06 ± 0,07              
  76--80                                                     1169       7,43 ± 0,08    3,43 ± 0,08              
  81--85                                                     293        9,61 ± 0,17    4,61 ± 0,17              
  86--90                                                     58         12,38 ± 0,34   6,38 ± 0,34              
  p value                                                    \< 0,005   \< 0,005                                
  **Patients surviving 30 days**                                                                                
                                                                                                                
  Age group                                                  N          EuroScore      Age-stripped EuroScore   
  \< 60                                                      2165       2,33 + 0,05    2,33 + 0,05              
  61--65                                                     1518       3,41 + 0,06    2,41 + 0,06              
  66--70                                                     1770       4,69 + 0,06    2,69 + 0,06              
  71--75                                                     1693       6,04 + 0,07    3,04 + 0,07              
  76--80                                                     1134       7,35 + 0,08    3,35 + 0,08              
  81--85                                                     276        9,54 + 0,18    4,54 + 0,18              
  86--90                                                     55         12,44 + 0,33   6,44 + 0,33              
  p value                                                    \< 0,005   \< 0,005                                
  **Patients dead during the first 30 postoperative days**                                                      
                                                                                                                
  Age group                                                  absolute   relative       EuroScore                Age-stripped EuroScore
  \< 60                                                      15         0,7%           5,13 ± 0,95              5,13 ± 0,95
  61--65                                                     21         1,4%           6,48 ± 0,91              5,48 ± 0,91
  66--70                                                     28         1,6%           6,68 ± 0,57              4,68 ± 0,57
  71--75                                                     38         2,2%           7,37 ± 0,49              4,37 ± 0,49
  76--80                                                     35         3,0%           9,91 ± 0,61              5,91 ± 0,61
  81--85                                                     17         5,8%           10,82 ± 0,56             5,82 ± 0,56
  86--90                                                     3          5,2%           11,33 ± 3,38             5,33 ± 3,38
  p value                                                    \< 0,005   \< 0,005       0,519                    

Tables [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"} summarize the surgical procedures performed in the seven age groups studied and show the corresponding 30-days mortalities. The relative number of coronary bypass surgeries, with a mortality rate of 1,1%, decreased with age in our patient population, whereas the number of aortic valve replacement procedures, either with or without accompanying coronary grafting, increased. The mortality for aortic valve replacement was 2,7% and 4,1% in the case of isolated and combined surgical procedures, respectively. Table [6](#T6){ref-type="table"} shows the incidence of postoperative complications. The 30-days mortality and the occurrence of most postoperative complications rose significantly with increasing age. The univariate analysis revealed a significant dependence of 30-days mortality on diabetes (p = 0,016) and atrial fibrillation (p \< 0,005). The stepwise logistic regression analysis showed a significant dependence of mortality on diabetes (p = 0,050).

###### 

Operative procedures

  Age group        \< 60   61--65   65--70   71--75   76--80   81--85   86--90                                             
  ---------------- ------- -------- -------- -------- -------- -------- -------- ------- ------ ------- ----- ------- ---- -------
                   n       \%       n        \%       n        \%       n        \%      n      \%      n     \%      n    \%
                                                                                                                           
  All procedures   2180    100      1539     100      1798     100      1731     100     1169   100     293   100     58   100
  CABG             1554    71,28    1126     73,16    1295     72,02    1185     68,46   739    63,22   132   45,05   26   44,83
  AVR              145     6,65     100      6,49     117      6,51     124      7,16    127    10,86   52    17,74   10   17,24
  AVR+CABG         62      2,84     56       3,64     102      5,67     118      6,82    128    10,95   60    20,48   13   22,41
  MVR              75      3,44     36       2,34     32       1,78     37       2,14    20     1,71    9     3,07    2    3,45
  AVR+MVR          10      0,46     5        0,32     5        0,28     15       0,87    7      0,59    1     0,34    0    0
  MVR+CABG         22      1,01     15       0,97     29       1,61     28       1,62    27     2,31    6     2,05    0    0
  OPCAB            98      4,49     74       4,81     69       3,84     73       4,22    30     2,57    18    6,14    4    6,89
  Other            214     9,82     127      8,25     149      8,29     151      8,72    91     7,78    15    5,12    3    5,17

CABG: coronary artery bypass grafting, AVR: aortic valve replacement, MVR: mitral valve repair or replacement, OPCAB: off-pump coronary artery bypass grafting, Other: redo procedures, surgery on thoracic aorta, repair of atrial septal defect, repair of postinfarction septal defect

###### 

30-days mortality

  Age group        \< 60   61--65   66--70   71--75   76--80   81--85   86--90   p value    All age groups
  ---------------- ------- -------- -------- -------- -------- -------- -------- ---------- ----------------
  All procedures   0,7%    1,4%     1,6%     2,2%     3,0%     5,8%     5,2%     \< 0,005   1,8%
  CABG             0,5%    1,0%     0,8%     1,4%     2,4%     1,5%     3,8%     \< 0,005   1,1%
  AVR              0,7%    3,0%     3,4%     1,6%     3,1%     7,7%     0        0,206      2,7%
  AVR+CABG         0       1,8%     3,9%     4,2%     2,3%     11,7%    15,4%    0,014      4,1%
  MVR              1,3%    2,8%     3,1%     5,4%     15,0%    11,1%    0        0,188      4,3%
  AVR+MVR          10,0%   0        0        6,7%     14,3%    100%     \-\--    0,049      9,3%
  MVR+CABG         9,1%    0        0        3,6%     3,7%     0        \-\--    0,519      3,1%
  OPCAB            0       0        1,5%     2,7%     3,3%     5,6%     0        0,352      1,4%
  Other            1,4%    3,9%     4,7%     6,0%     4,4%     6,7%     0        0,416      3,9%

CABG: coronary artery bypass grafting, AVR: aortic valve replacement, MVR: mitral valve repair or replacement, OPCAB: off-pump coronary artery bypass grafting, Other: redo procedures, surgery on thoracic aorta, repair of atrial septal defect, repair of postinfarction septal defect

###### 

Postoperative complications

  Age group                          \< 60   61--65   66--70   71--75   76--80   81--85   86--90   p value
  ---------------------------------- ------- -------- -------- -------- -------- -------- -------- ----------
  n                                  2180    1539     1798     1731     1169     293      58       \-\-\--
  Pneumonia                          7,8%    8,6%     9,0%     11,6%    11,7%    18,1%    6,9%     \< 0,005
  Arrhythmia                         31,6%   39,1%    48,2%    54,7%    60,5%    67,2%    70,7%    \< 0,005
  Myocardial infarction              1,2%    1,2%     1,7%     1,8%     1,7%     2,7%     1,7%     0,493
  Unstable sternum                   0,3%    0,6%     1,1%     0,9%     1,1%     1,4%     5,2%     0,001
  Significant pleural effusion       9,0%    11,0%    11,3%    13,5%    15,2%    16,0%    15,5%    \< 0,005
  Significant pericardial effusion   0,6%    0,8%     0,8%     1,2%     1,5%     2,7%     1,7%     0,016
  Cerebral vascular accident         1,7%    1,7%     2,1%     3,6%     3,8%     6,1%     8,6%     \< 0,005
  Confusion                          2,0%    4,2%     5,8%     9,3%     13,1%    21,2%    24,1%    \< 0,005
  Rethoracotomy                      2,6%    2,8%     3,2%     3,4%     3,3%     5,5%     5,2%     0,238
  Reintubation                       2,5%    3,0%     4,5%     4,4%     7,0%     7,8%     10,3%    \< 0,005
  Resuscitation                      1,8%    1,8%     2,6%     2,6%     3,0%     7,5%     1,7%     \< 0,005
  IABP                               0,7%    0,6%     0,6%     0,9%     1,1%     1,4%     0        0,622
  Dialysis                           1,6%    2,8%     3,0%     4,0%     6,4%     7,8%     13,8%    \< 0,005
  Laparotomy                         0,1%    0,1%     0,3%     0,1%     0,3%     0,3%     0        0,399
  30-days mortality                  0,7%    1,4%     1,6%     2,2%     3,0%     5,8%     5,2%     \< 0,005

Discussion
==========

The demographic changes result in a continuously increasing number of elderly patients being treated in cardiac surgery departments. In Germany, there exists no nation-wide database on the prevalence and incidence of those accompanying diseases studied in our patient group for the whole population, therefore, it is not possible to compare our patients with an age-matched group of subjects to determine any possible biological selection. If we consider the age-adjusted EuroSCORE as a measure of multimorbidity, then our data show an increase in multimorbidity in patients undergoing cardiac surgery with age. A detailed analysis of the individual EuroSCORE variables and the additional evaluation of other parameters confirm that the number of accompanying diseases in patients undergoing cardiac surgery increases with age. When compared with other age groups, the relatively small number of patients aged 80 years and over in our patient population allow only limited conclusions to be drawn from the data obtained in this specific group of patients. Alexander et al. \[[@B6]\] found the following significant differences between a group of 60161 patients aged below 80 years and undergoing an isolated CABG in comparison with a group of 4306 patients 80 years of age and older: female gender 28,2% vs. 44,1%, COPD 16,0% vs 14,1%, diabetes mellitus 29,5% vs. 23,0%, renal insufficiency 4,8% vs. 8,0%, chronic cardiac failure 11,7% vs. 19,4%, cerebrovascular disease 10,4% vs. 18,7%, peripheral vascular disease 13,7% vs. 16,4%, coronary triple vessel disease 64,3% vs. 70,4%. Also other studies indicate that age increases the multimorbidity in patients undergoing heart surgery \[[@B7],[@B8]\]. If we take this increasing multimorbidity into account, then the rise in 30-days mortality and occurrence of most postoperative complications with age, observed in our patient population, is not an unexpected result. Moreover, it is in harmony with the results of other research groups \[[@B6]-[@B9]\]. Also the reduction of the number of isolated coronary surgeries with increasing age, observed in our group of patients, corresponds with the findings of other authors \[[@B6],[@B8]\]. This surgical procedure is associated with a lower overall mortality when compared with the valve replacement and repair, as well as combined surgical procedures, nevertheless, it contributes to the increasing mortality with age. In the year 2000, the mortality for isolated CABG in Germany was 2,9%, 3,3% for isolated aortic valve replacement and 6,0% for simultaneous coronary bypass surgery with accompanying aortic valve replacement \[[@B2]\]. This issue is considered in the EuroSCORE evaluation in the risk factor called \"other than isolated CABG\".

In the patients, who died within 30 days after surgery, the EuroSCORE rose significantly with age, however, the score value did not show such significant changes after adjustment for age. Therefore, the question arises what is the reason for the increased mortality observed in the elderly and, further, what other factors are concealed behind the common variable \'age\'. The following four points have to be discussed with respect to this issue:

1\. Several diseases, e.g., COPD, peripheral atherosclerosis or renal insufficiency, are considered in the EuroSCORE analysis, however, the stage of the respective diseases and the intensity of the pathological processes, both of which are influenced by the time factor, are not taken into account. Therefore, the different intensity and duration of the mentioned diseases may be hidden in the EuroSCORE parameter \'age\'.

2\. The EuroSCORE risk evaluation system has been derived from a large database of cardiac surgical patients. Some diseases were not identified as being relevant with respect to mortality in this large patient population by the multivariate analysis and, therefore, were not considered during the generation of the EuroSCORE list of risk factors. We have studied the dependence of mortality on arterial hypertension, diabetes and atrial fibrillation, i.e., the three factors not included in the EuroSCORE system. All three factors exhibited significant differences in their respective age-related distributions. The univariate analysis determined a significant dependence of the 30-days mortality on diabetes and atrial fibrillation. The multivariate analysis revealed the dependence of the 30-days mortality on diabetes. The effect of such factors, that are not separately considered in the EuroSCORE analysis, may also partly contribute to the parameter \'age\'.

3\. The following factors are taken into account by the EuroSCORE system to characterize the cardiac status: instable angina, left ventricular ejection fraction 30--50% or \<30%, myocardial infarction within preceding 90 days before surgery, systolic pulmonary artery pressure \>60 mmHg. These patient data guarantee objective data acquisition and good comparability among hospitals with differing personnel and technology backgrounds and adequately describe certain aspects of the cardiac status. It would be inappropriate to expect the EuroSCORE system to consider in detail all characteristic features of the cardiovascular system in its complexity. However, one factor, shown to possess a high degree of diagnostic and therapeutic relevance in the elderly, the diastolic cardiac function \[[@B10]\], is not taken into account in the EuroSCORE cardiac operative risk evaluation. Senni et al. \[[@B11]\] have found out that 43% of patients with the primary diagnosis of cardiac failure exhibited normal systolic heart function. Other studies have shown that diastolic heart failure is found in about 50% of elderly patients suffering from congestive heart failure \[[@B12],[@B13]\]. This means, that also this aspect may be hidden in the EuroSCORE parameter \'age\'.

4\. Finally, the aging process is associated with structural and functional changes in various organ systems, which may influence the perioperative outcome. The following age-dependent changes in the cardiovascular system have previously been identified: dilation of large vessels, thickening of vessel walls, affecting first of all the intimal layer, loss of vessel elasticity \[[@B14]-[@B16]\], increase in left ventricular afterload \[[@B17]\], thickening of left ventricular wall \[[@B14],[@B18]\], cardiac myocyte cell loss and increase in the amount of myocardial collagen \[[@B19]\], decline in early diastolic left ventricular filling rate \[[@B20]\], increased atrial contribution to ventricular filling and larger atrial diameter \[[@B18]\], reduced adaptability of the cardiac response to different workloads resulting from modified ventricular filling volumes and changes in heart rate \[[@B17]\], increasing deficits in sympathetic modulation \[[@B21]\], changes in myocardial calcium hemostasis, affecting the excitation-contraction coupling and, consequently, the myocardial contractility and tendency to arrhythmias \[[@B22],[@B23]\]. The consequence of all the above-mentioned changes is the reduced cardiac adaptability to workload observed in the elderly \[[@B24],[@B25]\].

The age-dependent changes in other than cardiovascular body organ systems require specific preventive and therapeutic measures. For instance, the well-known age-related changes in lung structure and function (e.g., increase in functional residual capacity and residual volume, weakness of the expiratory muscles, malfunction of the airway epithelium accompanied with increased production of mucus, diminished tendency to cough, increased ventilation-perfusion mismatch) may lead to complications in older patients undergoing cardiac surgery. To prevent pulmonary complications in the elderly, it is necessary to examine the lung function and to initiate chest physiotherapy with breathing exercise already preoperatively. Early extubation, mobilisation, and pharmacologically supported bronchial clearance should follow postoperatively and a dehydration of the patients should be avoided. (A review of other therapeutic measures in elderly cardiac surgical patients is given in \[[@B26]\].)

Conclusions
===========

It can be summarized that age strongly correlates with a cluster of risk factors and organ dysfunctions, occurring during aging. However, the old age as such is not a disease. It is only a state characterized by a relatively high probability of suffering from various disturbances of the normal body function. From this point of view, age is a risk factor strongly correlating with mortality. Because of increased occurrence of age-related multimorbidity and changes in organ structure and function, special attention has to be paid to adequate therapeutic measures in elderly patients undergoing heart surgery.
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